|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 309/10 | |
| A61K 31/351 | |||
| A61P 3/10 |
| (11) | Number of the document | 3466939 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17802110.1 |
| Date of filing the European patent application | 2017-05-22 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/085295 |
| Date | 2017-05-22 |
| (87) | Number | WO 2017/202264 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 201610347924 | 2016-05-24 | CN |
| (72) |
LI, Xiang, CN
HE, Lei, CN
YU, Jun, CN
WANG, Jinjia, CN
DU, Zuyin, CN
|
| (73) |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Economic and Technological Development Zone Lianyungang, Jiangsu 222047,
CN
|
| (54) | NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |
| NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |